Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Grabbe

Showing results (251-260 of 325) with videos related to

Pageof 33
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)|December 2, 2024
Introducing Degradable Cationic Nanogels Carrying TLR9 Stimulating OligonucleotidesAlexander Fuchs, Christian Czysch, Konrad Maxeiner, et al.
Dermatology and Therapy|September 25, 2021
Light-Based Devices for the Treatment of Facial Erythema and TelangiectasiaVani Yepuri, Anant D Patil, Klaus Fritz, et al.
Clinical & Developmental Immunology|April 5, 2012
Adaptive immune response to model antigens is impaired in murine leukocyte-adhesion deficiency-1 revealing elevated activation thresholds in vivoThorsten Peters, Wilhelm Bloch, Oliver Pabst, et al.
European Journal of Immunology|September 19, 2006
Migration of immature mouse DC across resting endothelium is mediated by ICAM-2 but independent of beta2-integrins and murine DC-SIGN homologuesKlaus Wethmar, Yvonne Helmus, Kerstin Lühn, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 28, 2024
Real-world effectiveness and safety of the LAight-therapy in patients with hidradenitis suppurativaAlexandra Strobel, Michael Schultheis, Petra Staubach, et al.
The Journal of Dermatological Treatment|November 27, 2023
A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effectivenessMarcus Heise, Petra Staubach, Georgios Nikolakis, et al.
Nanomedicine (London, England)|September 16, 2016
Vaccination with trifunctional nanoparticles that address CD8<sup>+</sup> dendritic cells inhibits growth of established melanomaLimei Shen, Susanne Krauthäuser, Karl Fischer, et al.
Macromolecular Rapid Communications|March 26, 2022
End Group Dye-Labeled Polycarbonate Block Copolymers for Micellar (Immuno-)Drug DeliveryChristian Czysch, Carolina Medina-Montano, Nils-Jørgen Knudsen Dal, et al.
Advanced Healthcare Materials|September 24, 2024
PH-Triggered, Lymph Node Focused Immunodrug Release by Polymeric 2-Propionic-3-Methyl-maleic Anhydrides with Cholesteryl End GroupsAlina G Heck, Carolina Medina-Montano, Zifu Zhong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 23, 2013
Angiotensin II-induced vascular dysfunction depends on interferon-γ-driven immune cell recruitment and mutual activation of monocytes and NK-cellsSabine Kossmann, Melanie Schwenk, Michael Hausding, et al.
Pageof 33

Showing results (251-260 of 325) with videos related to

Sort By:
Pageof 33
Small (Weinheim an Der Bergstrasse, Germany)|December 2, 2024
Introducing Degradable Cationic Nanogels Carrying TLR9 Stimulating OligonucleotidesAlexander Fuchs, Christian Czysch, Konrad Maxeiner, et al.
Dermatology and Therapy|September 25, 2021
Light-Based Devices for the Treatment of Facial Erythema and TelangiectasiaVani Yepuri, Anant D Patil, Klaus Fritz, et al.
Clinical & Developmental Immunology|April 5, 2012
Adaptive immune response to model antigens is impaired in murine leukocyte-adhesion deficiency-1 revealing elevated activation thresholds in vivoThorsten Peters, Wilhelm Bloch, Oliver Pabst, et al.
European Journal of Immunology|September 19, 2006
Migration of immature mouse DC across resting endothelium is mediated by ICAM-2 but independent of beta2-integrins and murine DC-SIGN homologuesKlaus Wethmar, Yvonne Helmus, Kerstin Lühn, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 28, 2024
Real-world effectiveness and safety of the LAight-therapy in patients with hidradenitis suppurativaAlexandra Strobel, Michael Schultheis, Petra Staubach, et al.
The Journal of Dermatological Treatment|November 27, 2023
A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effectivenessMarcus Heise, Petra Staubach, Georgios Nikolakis, et al.
Nanomedicine (London, England)|September 16, 2016
Vaccination with trifunctional nanoparticles that address CD8<sup>+</sup> dendritic cells inhibits growth of established melanomaLimei Shen, Susanne Krauthäuser, Karl Fischer, et al.
Macromolecular Rapid Communications|March 26, 2022
End Group Dye-Labeled Polycarbonate Block Copolymers for Micellar (Immuno-)Drug DeliveryChristian Czysch, Carolina Medina-Montano, Nils-Jørgen Knudsen Dal, et al.
Advanced Healthcare Materials|September 24, 2024
PH-Triggered, Lymph Node Focused Immunodrug Release by Polymeric 2-Propionic-3-Methyl-maleic Anhydrides with Cholesteryl End GroupsAlina G Heck, Carolina Medina-Montano, Zifu Zhong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 23, 2013
Angiotensin II-induced vascular dysfunction depends on interferon-γ-driven immune cell recruitment and mutual activation of monocytes and NK-cellsSabine Kossmann, Melanie Schwenk, Michael Hausding, et al.
Pageof 33